Buchumschlag

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

Abstract - From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cross, Nicholas C. P. (VerfasserIn) , Ernst, Thomas (VerfasserIn) , Branford, Susan (VerfasserIn) , Cayuela, Jean-Michel (VerfasserIn) , Deininger, Michael (VerfasserIn) , Fabarius, Alice (VerfasserIn) , Kim, Dennis Dong Hwan (VerfasserIn) , Machova Polakova, Katerina (VerfasserIn) , Radich, Jerald P. (VerfasserIn) , Hehlmann, Rüdiger (VerfasserIn) , Hochhaus, Andreas (VerfasserIn) , Apperley, Jane F. (VerfasserIn) , Soverini, Simona (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 04 October 2023
In: Leukemia
Year: 2023, Jahrgang: 37, Heft: 11, Pages: 2150-2167
ISSN:1476-5551
DOI:10.1038/s41375-023-02048-y
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-023-02048-y
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-023-02048-y
Volltext
Verfasserangaben:Nicholas C.P. Cross, Thomas Ernst, Susan Branford, Jean-Michel Cayuela, Michael Deininger, Alice Fabarius, Dennis Dong Hwan Kim, Katerina Machova Polakova, Jerald P. Radich, Rüdiger Hehlmann, Andreas Hochhaus, Jane F. Apperley and Simona Soverini
Beschreibung
Zusammenfassung:Abstract - From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients. Our recommendations focus on current best practice and highlight the strengths and pitfalls of commonly used laboratory tests.
Beschreibung:Gesehen am 15.01.2024
Beschreibung:Online Resource
ISSN:1476-5551
DOI:10.1038/s41375-023-02048-y

Ähnliche Einträge